{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:59:11Z","timestamp":1771981151879,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current understanding of IL-23 biology, with its link to other pro-inflammatory cytokines, for example, IL-17 and granulocyte macrophage-colony stimulating factor (GM-CSF), is primarily focused on T lymphocyte-mediated inflammation\/autoimmunity. Pain is a significant symptom associated with many musculoskeletal conditions leading to functional impairment and poor quality of life. While the role of IL-23 in arthritis has been studied in mouse models of adaptive immune-mediated arthritis using targeted approaches (e.g., monoclonal antibody (mAb) neutralization), the literature on IL-23 and arthritis pain is limited. Encouragingly, the anti-IL-23p19 mAb, guselkumab, reduces pain in psoriatic arthritis patients. Recent evidence has suggested a new biology for IL-23, whereby IL-23 is required in models of innate immune-mediated arthritis and its associated pain with its action being linked to a GM-CSF-dependent pathway (the so-called GM-CSF\u2794CCL17 pathway). This Commentary discusses the current understanding of potential cytokine networks involving IL-23 in arthritis pain and provides a rationale for future clinical studies targeting IL-23p19 in arthritis pain.<\/jats:p>","DOI":"10.1186\/s13075-022-02777-y","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T07:06:59Z","timestamp":1650870419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of interleukin (IL)-23 in regulating pain in arthritis"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6609-3524","authenticated-orcid":false,"given":"Kevin M.-C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Sherlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-9224","authenticated-orcid":false,"given":"John A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"2777_CR1","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1007\/s10067-019-04656-5","volume":"38","author":"A Ramjeeawon","year":"2019","unstructured":"Ramjeeawon A, Choy E. Neuropathic-like pain in psoriatic arthritis: evidence of abnormal pain processing. Clin Rheumatol. 2019;38:3153\u20139.","journal-title":"Clin Rheumatol"},{"key":"2777_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13075-015-0761-8","volume":"17","author":"SM Koop","year":"2015","unstructured":"Koop SM, ten Klooster PM, Vonkeman HE, Steunebrink LM, van de Laar MA. Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis. Arthritis Res Ther. 2015;17:237.","journal-title":"Arthritis Res Ther"},{"key":"2777_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","volume":"139","author":"AI Basbaum","year":"2009","unstructured":"Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139:267\u201384.","journal-title":"Cell"},{"key":"2777_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","volume":"38","author":"FA Pinho-Ribeiro","year":"2017","unstructured":"Pinho-Ribeiro FA, Verri WA Jr, Chiu IM. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017;38:5\u201319.","journal-title":"Trends Immunol"},{"key":"2777_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13075-016-1185-9","volume":"18","author":"AD Cook","year":"2016","unstructured":"Cook AD, Louis C, Robinson MJ, Saleh R, Sleeman MA, Hamilton JA. Granulocyte macrophage colony-stimulating factor receptor alpha expression and its targeting in antigen-induced arthritis and inflammation. Arthritis Res Ther. 2016;18:287.","journal-title":"Arthritis Res Ther"},{"key":"2777_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pain.2009.06.002","volume":"145","author":"G Segond von Banchet","year":"2009","unstructured":"Segond von Banchet G, Boettger MK, Fischer N, Gajda M, Brauer R, Schaible HG. Experimental arthritis causes tumor necrosis factor-alpha-dependent infiltration of macrophages into rat dorsal root ganglia which correlates with pain-related behavior. Pain. 2009;145:151\u20139.","journal-title":"Pain"},{"key":"2777_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/annrheumdis-2012-201703","volume":"72","author":"AD Cook","year":"2013","unstructured":"Cook AD, Pobjoy J, Sarros S, Steidl S, Durr M, Lacey DC, et al. Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain. Ann Rheum Dis. 2013;72:265\u201370.","journal-title":"Ann Rheum Dis"},{"key":"2777_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000113","volume":"6","author":"R Shechter","year":"2009","unstructured":"Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009;6:e1000113.","journal-title":"PLoS Med"},{"key":"2777_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jpain.2014.01.491","volume":"15","author":"HL Willemen","year":"2014","unstructured":"Willemen HL, Eijkelkamp N, Garza Carbajal A, Wang H, Mack M, Zijlstra J, et al. Monocytes\/macrophages control resolution of transient inflammatory pain. J Pain. 2014;15:496\u2013506.","journal-title":"J Pain"},{"key":"2777_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715\u201325.","journal-title":"Immunity"},{"key":"2777_CR11","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278:1910\u20134.","journal-title":"J Biol Chem"},{"key":"2777_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233\u201340.","journal-title":"J Exp Med"},{"key":"2777_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nature08949","volume":"464","author":"S Buonocore","year":"2010","unstructured":"Buonocore S, Ahern PP, Uhlig HH, Ivanov DR II, Littman KJ, Maloy, and F. Powrie. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010;464:1371\u20135.","journal-title":"Nature"},{"key":"2777_CR14","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1084\/jem.20030896","volume":"198","author":"CA Murphy","year":"2003","unstructured":"Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198:1951\u20137.","journal-title":"J Exp Med"},{"key":"2777_CR15","doi-asserted-by":"publisher","first-page":"R194","DOI":"10.1186\/ar2893","volume":"11","author":"F Cornelissen","year":"2009","unstructured":"Cornelissen F, Mus AM, Asmawidjaja PS, van Hamburg JP, Tocker J, Lubberts E. Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells. Arthritis Res Ther. 2009;11:R194.","journal-title":"Arthritis Res Ther"},{"key":"2777_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057553","volume":"8","author":"F Cornelissen","year":"2013","unstructured":"Cornelissen F, Asmawidjaja PS, Mus AM, Corneth O, Kikly K, Lubberts E. IL-23 dependent and independent stages of experimental arthritis: no clinical effect of therapeutic IL-23p19 inhibition in collagen-induced arthritis. PLoS One. 2013;8:e57553.","journal-title":"PLoS One"},{"key":"2777_CR17","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/ar2297","volume":"9","author":"T Yago","year":"2007","unstructured":"Yago T, Nanke Y, Kawamoto M, Furuya T, Kobashigawa T, Kamatani N, et al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res Ther. 2007;9:R96.","journal-title":"Arthritis Res Ther"},{"key":"2777_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(20)30265-8","volume":"395","author":"A Deodhar","year":"2020","unstructured":"Deodhar A, Helliwell PS, Boehncke WH, Kollmeier AP, Hsia EC, Subramanian RA, et al. Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFalpha inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 2020;395:1115\u201325.","journal-title":"Lancet"},{"key":"2777_CR19","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(20)30263-4","volume":"395","author":"PJ Mease","year":"2020","unstructured":"Mease PJ, Rahman P, Gottlieb AB, Kollmeier AP, Hsia EC, Xu XL, et al. Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 2020;395:1126\u201336.","journal-title":"Lancet"},{"key":"2777_CR20","unstructured":"Mease P, Helliwell P, Gladman D, Poddubnyy D, Baraliakos X, Chakravarty S, et al. Efficacy of guselkumab, a monoclonal antibody that specifically binds to the p19 subunit of IL-23, on axial-related endpoints in patients with active PsA with imaging-confirmed sacroiliitis: week-52 results from two phase 3, randomized, double-blind, placebo-controlled studies [abstract]. Arthritis Rheumatol. 2020;72."},{"key":"2777_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/annrheumdis-2016-209831","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Agarwal SK, Ilivanova E, Xu XL, Miao Y, Zhuang Y, et al. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Ann Rheum Dis. 2017;76:831\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2777_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-020-02212-0","volume":"22","author":"KM Lee","year":"2020","unstructured":"Lee KM, Zhang Z, Achuthan A, Fleetwood AJ, Smith JE, Hamilton JA, et al. IL-23 in arthritic and inflammatory pain development in mice. Arthritis Res Ther. 2020;22:123.","journal-title":"Arthritis Res Ther"},{"key":"2777_CR23","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1172\/JCI87828","volume":"126","author":"A Achuthan","year":"2016","unstructured":"Achuthan A, Cook AD, Lee MC, Saleh R, Khiew HW, Chang MW, et al. Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation. J Clin Invest. 2016;126:3453\u201366.","journal-title":"J Clin Invest"},{"key":"2777_CR24","doi-asserted-by":"crossref","unstructured":"Cook AD, Lee MC, Saleh R, Khiew HW, Christensen AD, Achuthan A, et al. TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17. JCI Insight. 2018;3:e99249.","DOI":"10.1172\/jci.insight.99249"},{"key":"2777_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbi.2013.12.011","volume":"37","author":"C Bian","year":"2014","unstructured":"Bian C, Wang ZC, Yang JL, Lu N, Zhao ZQ, Zhang YQ. Up-regulation of interleukin-23 induces persistent allodynia via CX3CL1 and interleukin-18 signaling in the rat spinal cord after tetanic sciatic stimulation. Brain Behav Immun. 2014;37:220\u201330.","journal-title":"Brain Behav Immun"},{"key":"2777_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.expneurol.2006.03.014","volume":"200","author":"C Kleinschnitz","year":"2006","unstructured":"Kleinschnitz C, Hofstetter HH, Meuth SG, Braeuninger S, Sommer C, Stoll G. T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol. 2006;200:480\u20135.","journal-title":"Exp Neurol"},{"key":"2777_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature13199","volume":"510","author":"L Riol-Blanco","year":"2014","unstructured":"Riol-Blanco L, Ordovas-Montanes J, Perro M, Naval E, Thiriot A, Alvarez D, et al. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature. 2014;510:157\u201361.","journal-title":"Nature"},{"key":"2777_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.immuni.2015.08.016","volume":"43","author":"SW Kashem","year":"2015","unstructured":"Kashem SW, Riedl MS, Yao C, Honda CN, Vulchanova L, Kaplan DH. Nociceptive sensory fibers drive interleukin-23 production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity. Immunity. 2015;43:515\u201326.","journal-title":"Immunity"},{"key":"2777_CR29","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/bjd.12175","volume":"168","author":"EM Baerveldt","year":"2013","unstructured":"Baerveldt EM, Onderdijk AJ, Kurek D, Kant M, Florencia EF, Ijpma AS, et al. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response. Br J Dermatol. 2013;168:990\u20138.","journal-title":"Br J Dermatol"},{"key":"2777_CR30","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.cell.2019.06.022","volume":"178","author":"JA Cohen","year":"2019","unstructured":"Cohen JA, Edwards TN, Liu AW, Hirai T, Jones MR, Wu J, et al. Cutaneous TRPV1(+) neurons trigger protective innate type 17 anticipatory immunity. Cell. 2019;178:919\u2013932 e914.","journal-title":"Cell"},{"key":"2777_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11481-015-9589-x","volume":"10","author":"J Vilisaar","year":"2015","unstructured":"Vilisaar J, Kawabe K, Braitch M, Aram J, Furtun Y, Fahey AJ, et al. Reciprocal regulation of substance P and IL-12\/IL-23 and the associated cytokines, IFNgamma\/IL-17: a perspective on the relevance of this interaction to multiple sclerosis. J Neuroimmune Pharmacol. 2015;10:457\u201367.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2777_CR32","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.4049\/jimmunol.1002535","volume":"186","author":"P Cunin","year":"2011","unstructured":"Cunin P, Caillon A, Corvaisier M, Garo E, Scotet M, Blanchard S, et al. The tachykinins substance P and hemokinin-1 favor the generation of human memory Th17 cells by inducing IL-1beta, IL-23, and TNF-like 1A expression by monocytes. J Immunol. 2011;186:4175\u201382.","journal-title":"J Immunol"},{"key":"2777_CR33","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1128\/IAI.00358-08","volume":"76","author":"A Blum","year":"2008","unstructured":"Blum A, Setiawan T, Hang L, Stoyanoff K, Weinstock JV. Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation. Infect Immun. 2008;76:3651\u20136.","journal-title":"Infect Immun"},{"key":"2777_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115109","volume":"131","author":"S Sun","year":"2020","unstructured":"Sun S, Diggins NH, Gunderson ZJ, Fehrenbacher JC, White FA, Kacena MA. No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing. Bone. 2020;131:115109.","journal-title":"Bone"},{"key":"2777_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00281-018-0675-z","volume":"40","author":"JE Choi","year":"2018","unstructured":"Choi JE, Di Nardo A. Skin neurogenic inflammation. Semin Immunopathol. 2018;40:249\u201359.","journal-title":"Semin Immunopathol"},{"key":"2777_CR36","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.neuron.2021.06.015","volume":"109","author":"X Luo","year":"2021","unstructured":"Luo X, Chen O, Wang Z, Bang S, Ji J, Lee SH, et al. IL-23\/IL-17A\/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice. Neuron. 2021;109:2691\u20132706 e2695.","journal-title":"Neuron"},{"key":"2777_CR37","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1096\/fj.03-1367fje","volume":"18","author":"AF Sheibanie","year":"2004","unstructured":"Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 2004;18:1318\u201320.","journal-title":"FASEB J"},{"key":"2777_CR38","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1002\/art.22794","volume":"56","author":"AF Sheibanie","year":"2007","unstructured":"Sheibanie AF, Khayrullina T, Safadi FF, Ganea D. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23\/interleukin-17 axis. Arthritis Rheum. 2007;56:2608\u201319.","journal-title":"Arthritis Rheum"},{"key":"2777_CR39","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.4049\/jimmunol.178.12.8138","volume":"178","author":"AF Sheibanie","year":"2007","unstructured":"Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R, et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis. J Immunol. 2007;178:8138\u201347.","journal-title":"J Immunol"},{"key":"2777_CR40","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.1073\/pnas.0812782106","volume":"106","author":"HP Lemos","year":"2009","unstructured":"Lemos HP, Grespan R, Vieira SM, Cunha TM, Verri WA Jr, Fernandes KS, et al. Prostaglandin mediates IL-23\/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc Natl Acad Sci U S A. 2009;106:5954\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2777_CR41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.molimm.2012.08.014","volume":"53","author":"KW Kalim","year":"2013","unstructured":"Kalim KW, Groettrup M. Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit. Mol Immunol. 2013;53:274\u201382.","journal-title":"Mol Immunol"},{"key":"2777_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20082293","volume":"206","author":"K Boniface","year":"2009","unstructured":"Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling. J Exp Med. 2009;206:535\u201348.","journal-title":"J Exp Med"},{"key":"2777_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jaci.2018.05.036","volume":"143","author":"J Lee","year":"2019","unstructured":"Lee J, Aoki T, Thumkeo D, Siriwach R, Yao C, Narumiya S. T cell-intrinsic prostaglandin E2-EP2\/EP4 signaling is critical in pathogenic TH17 cell-driven inflammation. J Allergy Clin Immunol. 2019;143:631\u201343.","journal-title":"J Allergy Clin Immunol"},{"key":"2777_CR44","volume":"2015","author":"Q Shi","year":"2015","unstructured":"Shi Q, Yin Z, Zhao B, Sun F, Yu H, Yin X, et al. PGE2 elevates IL-23 production in human dendritic cells via a cAMP dependent pathway. Mediators Inflamm. 2015;2015:984690.","journal-title":"Mediators Inflamm"},{"key":"2777_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10495-018-1503-6","volume":"24","author":"J Gao","year":"2019","unstructured":"Gao J, Kong R, Zhou X, Ji L, Zhang J, Zhao D. Correction to: MiRNA-126 expression inhibits IL-23R mediated TNF-alpha or IFN-gamma production in fibroblast-like synoviocytes in a mice model of collagen-induced rheumatoid arthritis. Apoptosis. 2019;24:382.","journal-title":"Apoptosis"},{"key":"2777_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1471-4159.2005.03368.x","volume":"95","author":"CS Constantinescu","year":"2005","unstructured":"Constantinescu CS, Tani M, Ransohoff RM, Wysocka M, Hilliard B, Fujioka T, et al. Astrocytes as antigen-presenting cells: expression of IL-12\/IL-23. J Neurochem. 2005;95:331\u201340.","journal-title":"J Neurochem"},{"key":"2777_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4049\/jimmunol.2000315","volume":"205","author":"KM Lee","year":"2020","unstructured":"Lee KM, Jarnicki A, Achuthan A, Fleetwood AJ, Anderson GP, Ellson C, et al. CCL17 in inflammation and pain. J Immunol. 2020;205:213\u201322.","journal-title":"J Immunol"},{"key":"2777_CR48","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/exd.14206","volume":"29","author":"D Pavlenko","year":"2020","unstructured":"Pavlenko D, Funahashi H, Sakai K, Hashimoto T, Lozada T, Yosipovitch G, et al. IL-23 modulates histamine-evoked itch and responses of pruriceptors in mice. Exp Dermatol. 2020;29:1209\u201315.","journal-title":"Exp Dermatol"},{"key":"2777_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156666","volume":"11","author":"J Zeitz","year":"2016","unstructured":"Zeitz J, Ak M, Muller-Mottet S, Scharl S, Biedermann L, Fournier N, et al. Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS One. 2016;11:e0156666.","journal-title":"PLoS One"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02777-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T08:04:35Z","timestamp":1650873875000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02777-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2777"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02777-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KMCL and JAH declare that they have no competing interests. JS is an employee of Janssen and hold stock and stock options in the company.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}